Community-acquired meticillin-resistant Staphylococcus aureus strain USA300 resists staphylococcal protein A modulation by antibiotics and antimicrobial peptides

International Journal of Antimicrobial Agents

Volumn 45, Issue 1, 2015, Pages 19-24

  Cardot Martin, E ^a   Michel, A ^a   Raynal, B ^a   Badiou, C ^a,b   Laurent, F ^a,b   Vandenesch, F ^a,b   Etienne, J ^a,b   Lina, G ^a,b   Dumitrescu, O ^a,b  

^a UNIVERSITÉ LYON 1   (France)

^b HOSPICES CIVILS DE LYON   (France)

Author keywords

Antibiotic; Defensins; Peptide; Staphylococcus aureus

Indexed keywords

CLINDAMYCIN; HUMAN NEUTROPHIL PEPTIDE 1; HUMAN NEUTROPHIL PEPTIDE 2; HUMAN NEUTROPHIL PEPTIDE 3; LINEZOLID; MESSENGER RNA; POLYPEPTIDE ANTIBIOTIC AGENT; STAPHYLOCOCCUS PROTEIN A; TIGECYCLINE; UNCLASSIFIED DRUG; VANCOMYCIN; ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; VIRULENCE FACTOR;

ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GROWTH CURVE; INCUBATION TIME; LD 50; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRAIN DIFFERENCE; BIOSYNTHESIS; COMMUNITY ACQUIRED INFECTION; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; STAPHYLOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; COMMUNITY-ACQUIRED INFECTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; REAL-TIME POLYMERASE CHAIN REACTION; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL PROTEIN A; VIRULENCE FACTORS;

EID: 84920443555     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2014.08.009     Document Type: Article

References (29)

1. Y. Gillet, B. Issartel, P. Vanhems, J.C. Fournet, G. Lina, and M. Bes Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients Lancet 359 2002 753 759
2. A. Cunnington, T. Brick, M. Cooper, J. Danin, D. Hunt, and A. Jeanes Severe invasive Panton-Valentine leucocidin positive Staphylococcus aureus infections in children in London, UK J Infect 59 2009 28 36
3. F. Vandenesch, T. Naimi, M.C. Enright, G. Lina, G.R. Nimmo, and H. Heffernan Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence Emerg Infect Dis 9 2003 978 984
4. T.J. Foster, and M. Hook Surface protein adhesins of Staphylococcus aureus Trends Microbiol 6 1998 484 488
5. F. Falugi, H.K. Kim, D.M. Missiakas, and O. Schneewind Role of protein A in the evasion of host adaptive immune responses by Staphylococcus aureus MBio 4 2013 e00575 e613
6. A.M. Edwards, M.G. Bowden, E.L. Brown, M. Laabei, and R.C. Massey Staphylococcus aureus extracellular adherence protein triggers TNFα release, promoting attachment to endothelial cells via protein A PLoS ONE 7 2012 e43046
7. M.I. Gómez, A. Lee, B. Reddy, A. Muir, G. Soong, and A. Pitt Staphylococcus aureus protein A induces airway epithelial inflammatory responses by activating TNFR1 Nat Med 10 2004 842 848
8. O. Cirioni, C. Silvestri, R. Ghiselli, A. Giacometti, F. Orlando, and F. Mocchegiani Experimental study on the efficacy of combination of α-helical antimicrobial peptides and vancomycin against Staphylococcus aureus with intermediate resistance to glycopeptides Peptides 27 2006 2600 2606
9. A. Giacometti, O. Cirioni, M.S. Del Prete, A.M. Paggi, M.M. D'Errico, and G. Scalise Combination studies between polycationic peptides and clinically used antibiotics against Gram-positive and Gram-negative bacteria Peptides 21 2000 1155 1160
10. J.W. Lillard Jr., P.N. Boyaka, O. Chertov, J.J. Oppenheim, and J.R. McGhee Mechanisms for induction of acquired host immunity by neutrophil peptide defensins Proc Natl Acad Sci U S A 96 1999 651 656
11. T. Giesemann, G. Guttenberg, and K. Aktories Human α-defensins inhibit Clostridium difficile toxin B Gastroenterology 134 2008 2049 2058
12. R.I. Lehrer, G. Jung, P. Ruchala, W. Wang, E.D. Micewicz, and A.J. Waring Human α-defensins inhibit hemolysis mediated by cholesterol-dependent cytolysins Infect Immun 77 2009 4028 4040
13. M.C. Territo, T. Ganz, M.E. Selsted, and R. Lehrer Monocyte-chemotactic activity of defensins from human neutrophils J Clin Invest 84 1989 2017 2020
14. L. Yang, T.M. Weiss, R.I. Lehrer, and H.W. Huang Crystallization of antimicrobial pores in membranes: magainin and protegrin Biophys J 79 2000 2002 2009
15. K.A. Brogden Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3 2005 238 250
16. M.P. Otto, E. Martin, C. Badiou, S. Lebrun, M. Bes, and F. Vandenesch Effects of subinhibitory concentrations of antibiotics on virulence factor expression by community-acquired methicillin-resistant Staphylococcus aureus J Antimicrob Chemother 68 2013 1524 1532
17. C.G. Gemmell, and C.W. Ford Virulence factor expression by Gram-positive cocci exposed to subinhibitory concentrations of linezolid J Antimicrob Chemother 50 2002 665 672
18. S. Jarraud, C. Mougel, J. Thioulouse, G. Lina, H. Meugnier, and F. Forey Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles), and human disease Infect Immun 70 2002 631 641
19. J.M. Voyich, M. Otto, B. Mathema, K.R. Braughton, A.R. Whitney, and D. Welty Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? J Infect Dis 194 2006 1761 1770
20. B.A. Diep, A.M. Palazzolo-Ballance, P. Tattevin, L. Basuino, K.R. Braughton, and A.R. Whitney Contribution of Panton-Valentine leukocidin in community-associated methicillin-resistant Staphylococcus aureus pathogenesis PLoS ONE 3 2008 e3198
21. Clinical and Laboratory Standards Institute Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard 6th ed. 2007 CLSI Wayne, PA Document M07-A6
22. S. Rieg, B. Meier, E. Fahnrich, A. Huth, D. Wagner, and W.V. Kern Differential activity of innate defense antimicrobial peptides against Nocardia species BMC Microbiol 10 2010 61
23. F.Y. Chang, J.E. Peacock Jr., D.M. Musher, P. Triplett, B.B. MacDonald, and J.M. Mylotte Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study Medicine (Baltimore) 82 2003 333 339
24. C. Liu, A. Bayer, S.E. Cosgrove, R.S. Daum, S.K. Fridkin, and R.J. Gorwitz Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children Clin Infect Dis 52 2011 e18 e55
25. S.J. Yang, Y.Q. Xiong, M.R. Yeaman, K.W. Bayles, W. Abdelhady, and A.S. Bayer Role of the LytSR two-component regulatory system in adaptation to cationic antimicrobial peptides in Staphylococcus aureus Antimicrob Agents Chemother 57 2013 3875 3882
26. M.P. Trotonda, Y.Q. Xiong, G. Memmi, A.S. Bayer, and A.L. Cheung Role of mgrA and sarA in methicillin-resistant Staphylococcus aureus autolysis and resistance to cell wall-active antibiotics J Infect Dis 199 2009 209 218
27. S. Ingavale, W. van Wamel, T.T. Luong, C.Y. Lee, and A.L. Cheung Rat/MgrA, a regulator of autolysis, is a regulator of virulence genes in Staphylococcus aureus Infect Immun 73 2005 1423 1431
28. S. Herbert, P. Barry, and R.P. Novick Subinhibitory clindamycin differentially inhibits transcription of exoprotein genes in Staphylococcus aureus Infect Immun 69 2001 2996 3003
29. J.P. Rasigade, A. Moulay, Y. Lhoste, A. Tristan, M. Bes, and F. Vandenesch Impact of sub-inhibitory antibiotics on fibronectin-mediated host cell adhesion and invasion by Staphylococcus aureus BMC Microbiol 11 2011 263